|
| | HR0540 | | LRB103 36986 MST 67101 r |
|
|
1 | | HOUSE RESOLUTION |
2 | | WHEREAS, Turner Syndrome (TS) is a chromosomal abnormality |
3 | | that randomly affects those born female; it occurs when the |
4 | | secondary X chromosome is partially or completely missing; |
5 | | many have mosaic Turner Syndrome, for which the number of X |
6 | | chromosomes can vary; and |
7 | | WHEREAS, Most fetuses (98-99%) with Turner Syndrome will |
8 | | die before birth, resulting in approximately 10% of all |
9 | | first-trimester miscarriages, and one in 2,000 live female |
10 | | births has Turner Syndrome; those who do survive often face |
11 | | lifelong physical, emotional, cognitive, and/or psychological |
12 | | challenges that can be mitigated with early diagnosis and |
13 | | treatment; and |
14 | | WHEREAS, More than 30% of individuals born with Turner |
15 | | Syndrome are not diagnosed until they are 15 years of age, and |
16 | | only 3.5% receive adequate care; however, with increased |
17 | | awareness, the livelihoods of those affected can be greatly |
18 | | improved; there are over 85,337 individuals living with this |
19 | | condition in the U.S.; and |
20 | | WHEREAS, An increase in awareness for Turner Syndrome can |
21 | | help those with the condition and can lead to earlier |
22 | | diagnosis and better treatment; and |